SCHEMBL5820160

SCHEMBL5820160

CCOC(=O)c1cc(C#C[Si](C)(C)C)c(N)nc1OCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.52
HSD17B10 Q99714 1/20 0.52
ALDH1A1 P00352 5/20 0.39
RAB9A P51151 5/20 0.39
NPC1 O15118 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
GAA P10253 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CDC7 O00311 1/20 0.39
DBF4 Q9UBU7 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK1 P28482 1/20 0.39
HSP90AA1 P07900 1/20 0.39
IDO1 P14902 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5818552 0.81 PRKD3 (0.40) KDM4EHSD17B10ALDH1A1RAB9ANPC1
SCHEMBL5818003 0.79 KDM4E (0.46) KDM4EHSD17B10ALDH1A1RAB9ANPC1
SCHEMBL4770073 0.77 GAA (0.46) KDM4EHSD17B10ALDH1A1SMN1; SMN2GAA
SCHEMBL1313671 0.74 ALDH1A1 (0.49) KDM4EHSD17B10ALDH1A1RAB9ANPC1
SCHEMBL2012376 0.74 KDM4E (0.53) KDM4EHSD17B10ALDH1A1RAB9ANPC1
SCHEMBL14465322 0.74 HSD17B10 (0.44) KDM4EHSD17B10ALDH1A1SMN1; SMN2GAA
SCHEMBL5818365 0.73 KDM4E (0.51) KDM4EHSD17B10ALDH1A1SMN1; SMN2GAA
SCHEMBL1316499 0.71 ALDH1A1 (0.45) KDM4EHSD17B10ALDH1A1RAB9ANPC1
SCHEMBL23754407 0.71 KDM4E (0.55) KDM4EHSD17B10ALDH1A1SMN1; SMN2GAA
SCHEMBL5925812 0.70 KDM4E (0.41) KDM4EHSD17B10ALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006112828-A1 AZAINDOLE DERIVATIVES AS INHIBITORS OF P38 KINASE SCIOS, INC. (US) 2006-10-26 WO disclosed
US-20050288299-A1 Azaindole derivatives as inhibitors of p38 kinase SCIOS INC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288299-A1 Azaindole derivatives as inhibitors of p38 kinase MAPKAPK2, MAPK1, MAPK3 KDM4E 2446/4885HSD17B10 3767/4885ALDH1A1 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.